Morphine Sulfate 2 mg/mL PF Injection. 1 mL in a 3ml Sterile Single-Dose Syringe. 8265 Commerica...

FDA Drug Recall #D-0699-2018 — Class II — April 11, 2018

Recall Summary

Recall Number D-0699-2018
Classification Class II — Moderate risk
Date Initiated April 11, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Premier Pharmacy Labs Inc
Location Weeki Wachee, FL
Product Type Drugs
Quantity 4555 syringes

Product Description

Morphine Sulfate 2 mg/mL PF Injection. 1 mL in a 3ml Sterile Single-Dose Syringe. 8265 Commerical Way Weeki Wachee, FL 34613. NDC 69623-129-10

Reason for Recall

Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.

Distribution Pattern

Nationwide in the USA

Lot / Code Information

Lots: MOR030518IJDSA, MOR030518IJDSB, MOR030518IJDSC, MOR030518IJDSD, MOR030518IJDSE BUD: 06/03/2018;

Other Recalls from Premier Pharmacy Labs Inc

Recall # Classification Product Date
D-1421-2019 Class II Naloxone HCL Preserved INJ, 500mg/50mL (10mg/mL... Jun 18, 2019
D-1415-2019 Class II Droperidol Injectable Sterile Solution, 0.625mg... Jun 18, 2019
D-1412-2019 Class II Brilliant Blue Ophthalmic PF INJ, 0.5mg/mL (0.0... Jun 18, 2019
D-1422-2019 Class II Neostigmine Methylsulfate, 5mg/5mL (1mg/mL), 5m... Jun 18, 2019
D-1427-2019 Class II SUCCINYLcholine Chloride, 100mg/5mL (20mg/mL), ... Jun 18, 2019

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.